AVP and Stroke: Adjustments for age, obese (yes vs. no), previous CVD events (yes vs. no), NHISS, stroke syndrome (TACS vs. other), stroke subtype (Cardioembolic vs. other), acute treatment (no vs. yes), serum levels of glucose, CRP, eGFR, copeptin and NT-ProBNP, per one-unit(μg/mL) increase in adiponectin, the risk of mortality increased by 17% (HR, 1.17; 95%CI 1.11–1.24), Table 3.